Industry News
Prolonged survival in graft-versus-host disease study
Cynata Therapeutics has announced positive interim data from a proof-of-concept study of its lead Cymerus MSC product, CYP-001, with the product demonstrating prolonged patient survival. [ + ]
Grand Challenges Explorations Round 17 open
The Bill & Melinda Gates Foundation is currently accepting applications for the 17th round of Grand Challenges Explorations, an initiative to encourage innovative and unconventional global health and development solutions.
[ + ]What's your risk of breaking a bone?
Researchers from the University of Southampton have led a study into the risks of an individual experiencing a fracture in their lifetime. [ + ]
Rapid identification of CRISPR-Cas system PAMs
CRISPR-Cas systems are the latest generation of genetic tools, but these tools require researchers to identify the protospacer-adjacent motifs (PAMs) that unlock each system's functionality. [ + ]
Australian appointed Chief Scientist of The Nature Conservancy
Professor Hugh Possingham has been announced as Chief Scientist of The Nature Conservancy, a leading conservation organisation. [ + ]
Five new genetic markers for glaucoma
Researchers has discovered five previously unknown genetic areas linked to an increased risk of primary angle closure glaucoma — the leading cause of irreversible blindness worldwide. [ + ]
Citizen scientists to create a 'feather map of Australia'
By collecting wetland bird feathers, ordinary Australians can help researchers create the first ever 'Feather Map of Australia' to show the health of our wetland birds nationally. [ + ]
Mystery disease identified and potential cure found
An international research team has identified the mysterious disease afflicting families in Belgium, England and France for the past several decades — as well as a potential cure. [ + ]
Malaria from the age of the dinosaurs?
A researcher from Oregon State University has claimed that malaria evolved in insects at least 100 million years ago. His research suggests that the first vertebrate hosts of this disease were probably reptiles, which at that time would have included the dinosaurs. [ + ]
Plans for Phase 3 smoking cessation trial underway
Invion has met with the US FDA to discuss Phase 3 plans for development of oral INV102 (nadolol) as a treatment for patients with chronic obstructive pulmonary disease (COPD) who cannot quit cigarette smoking. [ + ]
Get GHS ready at a forum near you
Comcare is holding a series of Australia-wide forums focusing on the transition to the new international system of chemical labelling and classification. [ + ]
Repairing blood vessels to improve anticancer treatment
A new drug could be used to repair the blood vessel defects that prevent current anticancer treatments from entering tumours. [ + ]
Australia has a diverse STEM workforce — but still lacking in women
The Office of the Chief Scientist has released a detailed analysis of Australia's science, technology, engineering and mathematics (STEM) trained workforce. [ + ]
MoU to strengthen biomedical science partnership
The Australian Institute of Medical Scientists and the UK Institute of Biomedical Science have signed a memorandum of understanding that is intended to strengthen the partnership between the two organisations. [ + ]
FameLab's NSW semifinalists live on stage
Semifinalists in the science communication competition FameLab will take to the stage on 7 April at the Powerhouse Museum, Sydney. [ + ]

